Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001641172-25-003814
Filing Date
2025-04-11
Accepted
2025-04-11 16:05:42
Documents
94
Period of Report
2024-12-31

Document Format Files

Seq Description Document Type Size
1 form10-k.htm   iXBRL 10-K 3582872
2 ex3-5_3.htm EX-3.5_3 15766
3 ex3-6_1.htm EX-3.6_1 18250
4 ex4-1.htm EX-4.1 101839
5 ex10-45.htm EX-10.45 42957
6 ex19-1.htm EX-19.1 41034
7 ex23-1.htm EX-23.1 4262
8 ex31-1.htm EX-31.1 18440
9 ex31-2.htm EX-31.2 14349
10 ex32-1.htm EX-32.1 7050
11 ex32-2.htm EX-32.2 7035
12 form10-k_001.jpg GRAPHIC 36630
13 form10-k_002.jpg GRAPHIC 66502
14 form10-k_003.jpg GRAPHIC 27786
15 form10-k_004.jpg GRAPHIC 63386
16 form10-k_005.jpg GRAPHIC 37762
17 form10-k_006.jpg GRAPHIC 33352
18 form10-k_007.jpg GRAPHIC 47091
19 form10-k_008.jpg GRAPHIC 17239
20 form10-k_009.jpg GRAPHIC 31291
21 form10-k_010.jpg GRAPHIC 22598
  Complete submission text file 0001641172-25-003814.txt   13773511

Data Files

Seq Description Document Type Size
22 XBRL SCHEMA FILE tnfa-20241231.xsd EX-101.SCH 74026
23 XBRL CALCULATION FILE tnfa-20241231_cal.xml EX-101.CAL 78339
24 XBRL DEFINITION FILE tnfa-20241231_def.xml EX-101.DEF 354285
25 XBRL LABEL FILE tnfa-20241231_lab.xml EX-101.LAB 675128
26 XBRL PRESENTATION FILE tnfa-20241231_pre.xml EX-101.PRE 517928
96 EXTRACTED XBRL INSTANCE DOCUMENT form10-k_htm.xml XML 1811467
Mailing Address 1185 AVENUE OF THE AMERICAS SUITE 249 NEW YORK NY 10036
Business Address 1185 AVENUE OF THE AMERICAS SUITE 249 NEW YORK NY 10036 856-848-8698
TNF Pharmaceuticals, Inc. (Filer) CIK: 0001321834 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-36268 | Film No.: 25831632
SIC: 2835 In Vitro & In Vivo Diagnostic Substances
(CF Office: 03 Life Sciences)